跳至主要内容
临床试验/NCT05894460
NCT05894460招募中不适用

Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion: a Single-centre, Prospective Observational Study

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 254 人开始时间: 2023年6月27日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
254
试验地点
1
主要终点
Primary patency

研究概览

简要总结

This study will assess the safety and efficacy of Chocolate balloons as a combination with drug-coated balloons in the treatment of popliteal artery lesions in lower limb atherosclerotic occlusive disease and will compare them with conventional balloons.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rutherford classification of 2-6 in patients with femoropopliteal atherosclerotic occlusive disease;
  • primary cases with no previous surgical treatment of the target lesion;
  • presence of at least one vessel with patency in the distal outflow tract;
  • survival >1 year.

排除标准

  • planned stenting;
  • presence of flow-limiting dissection prior to application of Chocolate balloon and conventional balloon dilation of the target lesion;
  • combination of severe organ dysfunction of the heart, lungs and brain that cannot tolerate the procedure;
  • allergy to contrast agents, anaesthetic drugs, anticoagulants and anti-platelet drugs;
  • ineffective recanalization attempts;
  • lesions within or adjacent to the aneurysm, or the presence of a popliteal aneurysm.

结局指标

主要结局

Primary patency

时间窗: 12 months

No occlusion or restenosis (\>50%) of the target vessel in the treated segment during follow-up and no further intervention is required.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验